Finding that an in-house lawyer tried to deceive the U.S. Patent and Trademark Office, a federal judge ruled Abbott Laboratories’ patent unenforceable.

Illinois-based Abbott had sued Bayer and other pharmaceutical makers over a patent on strips used by diabetics to test their blood. Judge William Alsup of the Northern District of California made a finding of inequitable conduct on June 24, saying that the patent in question had been obtained only because Abbott attorney Lawrence Pope had withheld key information in connection with the patent filing.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]